)
Edge
Extra Everything: The Story of Chipotle
Chipotle's story from a single restaurant to a nationwide chain, through crisis and turnaround, built on one of the strongest models in the industry.
vTv Therapeutics
vTv Therapeutics (VTVT) investor relations material
vTv Therapeutics Proxy filing summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Proxy filing summary10 Jun, 2026
Executive summary
Adjourned annual meeting rescheduled for June 26, 2026, to allow review of a new executive compensation proposal.
Stockholders will vote on director elections, auditor ratification, and an advisory say-on-pay proposal.
Revised proxy materials and voting instructions provided, with extended deadlines for voting.
Voting matters and shareholder proposals
Proposal 1: Elect seven director nominees to serve until the next annual meeting.
Proposal 2: Ratify Ernst & Young LLP as independent auditor for fiscal year ending December 31, 2026.
Proposal 3: Advisory vote to approve named executive officer compensation, added via supplement.
Board recommends voting “FOR” all three proposals.
Voting can be done online, by phone, by mail, or virtually at the meeting.
Board of directors and corporate governance
Seven director nominees listed: Srinivas Akkaraju, Raymond Cheong, Fahed Al Marzooqi, Richard S. Nelson, Anne M. Phillips, Paul Sekhri, Daniel K. Spiegelman.
Directors to serve until the next annual meeting or until successors are elected and qualified.
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from vTv Therapeutics
- Phase III oral therapy for T1D nears enrollment completion, targeting major unmet need.VTVT
38th Annual Roth Conference15 Jun 2026 - Phase III oral therapy for T1D targets hypoglycemia and A1C reduction, data due year-end.VTVTTD Cowen 46th Annual Health Care Conference13 Jun 2026
- Cash surged from $51M financing, but pivotal diabetes trial remains on FDA clinical hold.VTVTQ2 20243 Jun 2026
- Net loss narrowed and cash position improved, but FDA hold delays lead diabetes program.VTVTQ3 20243 Jun 2026
- FDA lifts clinical hold, Phase 3 diabetes trial resumes Q2 2025; cash rises, net loss narrows.VTVTQ4 20243 Jun 2026
- Q1 net loss $5.1M, cash $31.1M, expedited Phase 3 trial, ongoing funding risk.VTVTQ1 20251 Jun 2026
- Net loss rose to $6.0M in Q2 2025 as Phase 3 cadisegliatin trial began and cash declined.VTVTQ2 20251 Jun 2026
- Net loss rose to $8.7M, cash reached $98.5M, and pivotal trial data expected in H2 2026.VTVTQ3 20251 Jun 2026
- Q1 2026 delivered $36.8M revenue and $24.1M net income, fueled by major licensing deals.VTVTQ1 20261 Jun 2026
Next vTv Therapeutics earnings date
AGM 202626 Jun, 2026
vTv Therapeutics
Next vTv Therapeutics earnings date
AGM 202626 Jun, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
Related articles
)
)
Frequently asked questions
Explore our global coverage